应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRBP Corbus Pharmaceuticals Holdings, Inc.
休市中 08-23 16:00:00 EDT
59.70
+0.18
+0.30%
盘后
59.70
+0.00
0.00%
19:27 EDT
最高
61.48
最低
58.85
成交量
24.87万
今开
60.00
昨收
59.52
日振幅
4.43%
总市值
7.19亿
流通市值
5.77亿
总股本
1,204万
成交额
1,485万
换手率
2.57%
流通股本
966.05万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速跳水5.04%报55.27美元
自选股智能写手 · 08-20
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速跳水5.04%报55.27美元
Corbus Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.10%报56.25美元
自选股智能写手 · 08-20
Corbus Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.10%报56.25美元
Corbus Pharmaceuticals Holdings, Inc.2024财年第二财季实现净利润-10.00百万美元,同比减少13.90%
自选股智能写手 · 08-17
Corbus Pharmaceuticals Holdings, Inc.2024财年第二财季实现净利润-10.00百万美元,同比减少13.90%
Corbus Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.08%
自选股智能写手 · 08-16
Corbus Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.08%
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速下挫5.52%
自选股智能写手 · 08-13
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速下挫5.52%
异动解读 | Corbus Pharmaceuticals股价大涨5.28% 公司产品线获关注
异动解读 · 08-09
异动解读 | Corbus Pharmaceuticals股价大涨5.28% 公司产品线获关注
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速上涨5.07%
自选股智能写手 · 08-09
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速上涨5.07%
Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫5.55%报50.00美元
自选股智能写手 · 08-08
Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫5.55%报50.00美元
Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅拉升5.40%
自选股智能写手 · 08-06
Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅拉升5.40%
Corbus Pharmaceuticals Holdings Inc 预计每股亏损 1.19 美元 - 财报前瞻
Reuters · 08-02
Corbus Pharmaceuticals Holdings Inc 预计每股亏损 1.19 美元 - 财报前瞻
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速拉升5.21%报58.55美元
自选股智能写手 · 07-30
Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速拉升5.21%报58.55美元
Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨6.35%报58.97美元
自选股智能写手 · 07-26
Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨6.35%报58.97美元
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.01%
自选股智能写手 · 07-25
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.01%
HC Wainwright & Co.:重申Corbus Pharmaceuticals(CRBP.US)买入评级, 目标价80.
智通财经 · 07-22
HC Wainwright & Co.:重申Corbus Pharmaceuticals(CRBP.US)买入评级, 目标价80.
Corbus Pharmaceuticals Holdings, Inc.盘中异动 临近午盘大幅跳水5.09%报55.95美元
自选股智能写手 · 07-18
Corbus Pharmaceuticals Holdings, Inc.盘中异动 临近午盘大幅跳水5.09%报55.95美元
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.16%
自选股智能写手 · 07-12
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.16%
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.32%报54.23美元
自选股智能写手 · 07-11
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.32%报54.23美元
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.35%
自选股智能写手 · 07-01
Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.35%
Corbus Pharmaceuticals(CRBP.US)获B. Riley Securities首次覆盖,给予买入评级, 目标价85.
智通财经 · 06-26
Corbus Pharmaceuticals(CRBP.US)获B. Riley Securities首次覆盖,给予买入评级, 目标价85.
美国研究综述-金宝汤,特斯拉,沃尔格林
Reuters · 06-26
美国研究综述-金宝汤,特斯拉,沃尔格林
暂无数据
公司概况
公司名称:
Corbus Pharmaceuticals Holdings, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Corbus Pharmaceuticals Holdings, Inc.于2009年4月24日根据特拉华州法律注册成立。Corbus是一家精准肿瘤学公司,拥有多元化的产品组合,致力于通过将创新的科学方法引入已被广泛理解的生物途径,帮助人们战胜严重疾病。该公司的管线由两种针对实体瘤的实验药物组成:CRB-701,一种下一代抗体药物偶联物,靶向Nectin-4在癌细胞上的表达以释放细胞毒性有效载荷,CRB-601,一种抗整合素单克隆抗体,可阻断癌细胞上表达的TGFβ的激活。
发行价格:
--
{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals Holdings, Inc.","latestPrice":59.7,"timestamp":1724443200000,"preClose":59.52,"halted":0,"volume":248749,"hourTrading":{"tag":"盘后","latestPrice":59.7,"preClose":59.7,"latestTime":"19:27 EDT","volume":52805,"amount":3152477.72,"timestamp":1724455676718},"delay":0,"floatShares":9660477,"shares":12043940,"eps":-4.957825,"marketStatus":"休市中","marketStatusCode":7,"change":0.18,"latestTime":"08-23 16:00:00 EDT","open":60,"high":61.48,"low":58.845,"amount":14847908.155927,"amplitude":0.044271,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.957825,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":59.52,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":60.27,"preClose":59.52,"latestTime":"09:21 EDT","volume":11,"amount":655.36999,"timestamp":1724419305774},"postHourTrading":{"tag":"盘后","latestPrice":59.7,"preClose":59.7,"latestTime":"19:27 EDT","volume":52805,"amount":3152477.72,"timestamp":1724455676718},"volumeRatio":0.8141883159134479,"impliedVol":1.6237,"impliedVolPercentile":0.958},"requestUrl":"/m/hq/s/CRBP/tweets","defaultTab":"tweets","newsList":[{"id":"2460007114","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速跳水5.04%报55.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460007114","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460007114?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:14","pubTimestamp":1724163265,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时14分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价快速下跌5.04%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082022142598e3589e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082022142598e3589e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2460608057","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.10%报56.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460608057","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460608057?lang=zh_cn&edition=full","pubTime":"2024-08-20 01:35","pubTimestamp":1724088929,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日01时35分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价快速上涨5.10%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.85%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082001352998e35663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082001352998e35663&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2460924130","title":"Corbus Pharmaceuticals Holdings, Inc.2024财年第二财季实现净利润-10.00百万美元,同比减少13.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460924130","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460924130?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824033,"startTime":"0","endTime":"0","summary":"8月17日,Corbus Pharmaceuticals Holdings, Inc.公布财报,公告显示公司2024财年第二财季净利润为-10.00百万美元,同比减少13.90%;其中营业收入为0.00美元,每股基本收益为-0.90美元。机构评级:截至2024年8月17日,当前有6家机构对Corbus Pharmaceuticals Holdings, Inc.目标价做出预测,其中目标均价为82.67美元,其中最低目标价为76.00美元,最高目标价为88.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000528959f2c97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000528959f2c97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP"],"gpt_icon":0},{"id":"2459045064","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459045064","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459045064?lang=zh_cn&edition=full","pubTime":"2024-08-16 03:27","pubTimestamp":1723750038,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日03时27分,Corbus Pharmaceuticals Holdings, Inc.股票出现异动,股价快速拉升5.08%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081603271898e35156&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081603271898e35156&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2459934319","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速下挫5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459934319","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459934319?lang=zh_cn&edition=full","pubTime":"2024-08-13 01:34","pubTimestamp":1723484088,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日01时34分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价急速跳水5.52%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.84%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013448af971926&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013448af971926&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"1170356431","title":"异动解读 | Corbus Pharmaceuticals股价大涨5.28% 公司产品线获关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1170356431","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170356431?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:14","pubTimestamp":1723212878,"startTime":"0","endTime":"0","summary":"北京时间2024年8月9日,生物技术公司Corbus Pharmaceuticals Holdings, Inc.股价盘中大涨5.28%,报收于56.32美元/股。公司旗下多元化产品线获市场关注,或是推动股价上涨的主因。- CRB-701,一种针对癌细胞上Nectin-4表达的下一代抗体药物偶联物;- CRB-601,一种可阻断癌细胞上TGF激活的抗整合素单克隆抗体;公司致力于通过将科学方法引入人们熟知的生物途径,帮助人们战胜严重疾病。其产品线覆盖肿瘤、自身免疫性疾病和代谢紊乱等多个领域,前景备受市场期待。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2458591510","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458591510","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458591510?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:09","pubTimestamp":1723212597,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时09分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价急速上涨5.07%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为1.47%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809220957af96d457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809220957af96d457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2457137829","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫5.55%报50.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457137829","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457137829?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:03","pubTimestamp":1723046593,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日00时03分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价急速下挫5.55%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为1.56%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808000313aefdbd6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808000313aefdbd6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2457023983","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023983","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023983?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:39","pubTimestamp":1722951575,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时39分,Corbus Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅拉升5.40%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213935968245e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213935968245e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2456231659","title":"Corbus Pharmaceuticals Holdings Inc 预计每股亏损 1.19 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456231659","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456231659?lang=zh_cn&edition=full","pubTime":"2024-08-02 23:54","pubTimestamp":1722614049,"startTime":"0","endTime":"0","summary":" * Corbus Pharmaceuticals Holdings Inc 预计在8月6日公布截至2024年6月30日的业绩时,季度收入将不会有任何变化(预计) * * LSEG 的分析师平均预计 Corbus Pharmaceuticals Holdings Inc 每股亏损 1.19 美元。* 华尔街对 Corbus Pharmaceuticals Holdings Inc 的 12 个月目标价中位数为 81.00 美元,高于其最新收盘价 59.07 美元。8月2日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Corbus Pharmaceuticals Holdings Inc 预计每股亏损 1.19 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2455772930","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速拉升5.21%报58.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455772930","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455772930?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:33","pubTimestamp":1722346382,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时33分,Corbus Pharmaceuticals Holdings, Inc.股票出现异动,股价快速拉升5.21%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213302af94dba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213302af94dba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2454232699","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨6.35%报58.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454232699","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454232699?lang=zh_cn&edition=full","pubTime":"2024-07-26 22:02","pubTimestamp":1722002550,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日22时02分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价快速上涨6.35%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072622023096820d1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072622023096820d1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2454380388","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454380388","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454380388?lang=zh_cn&edition=full","pubTime":"2024-07-25 00:43","pubTimestamp":1721839400,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日00时43分,Corbus Pharmaceuticals Holdings, Inc.股票出现异动,股价急速跳水5.01%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250043209681fe26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250043209681fe26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2453190750","title":"HC Wainwright & Co.:重申Corbus Pharmaceuticals(CRBP.US)买入评级, 目标价80.","url":"https://stock-news.laohu8.com/highlight/detail?id=2453190750","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453190750?lang=zh_cn&edition=full","pubTime":"2024-07-22 18:30","pubTimestamp":1721644259,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2452439519","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 临近午盘大幅跳水5.09%报55.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452439519","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452439519?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:57","pubTimestamp":1721318251,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时57分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价快速下挫5.09%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体跌幅为2.17%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182357319681e1df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182357319681e1df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2450537403","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450537403","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450537403?lang=zh_cn&edition=full","pubTime":"2024-07-12 23:19","pubTimestamp":1720797573,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日23时19分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价大幅拉升5.16%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为1.54%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712231934aef97dc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712231934aef97dc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2450369212","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.32%报54.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450369212","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450369212?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:31","pubTimestamp":1720708283,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时31分,Corbus Pharmaceuticals Holdings, Inc.股票出现异动,股价大幅拉升5.32%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711223124aef93fb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711223124aef93fb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2448116609","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448116609","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448116609?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:53","pubTimestamp":1719845616,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时53分,Corbus Pharmaceuticals Holdings, Inc.股票出现波动,股价急速拉升5.35%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.54%。Corbus Pharmaceuticals Holdings, Inc.公司简介:Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司,致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701225336af900a61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701225336af900a61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2446368418","title":"Corbus Pharmaceuticals(CRBP.US)获B. Riley Securities首次覆盖,给予买入评级, 目标价85.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446368418","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446368418?lang=zh_cn&edition=full","pubTime":"2024-06-26 18:11","pubTimestamp":1719396666,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2446337876","title":"美国研究综述-金宝汤,特斯拉,沃尔格林","url":"https://stock-news.laohu8.com/highlight/detail?id=2446337876","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446337876?lang=zh_cn&edition=full","pubTime":"2024-06-26 15:15","pubTimestamp":1719386124,"startTime":"0","endTime":"0","summary":" 路透6月26日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括金宝汤、特斯拉和沃尔格林。* Aerovironment Inc :BTIG给予买入评级,目标价255美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKLB","LU0266013472.USD","TSLL","ATI","LU1861220033.SGD","BK4154","AKR","CRS","OSCR","IE00BWXC8680.SGD","CRBP","OKE","CPB","IE00B19Z3581.USD","BK4527","SMPL","HUM","HWM","LU0070302665.USD","SNX","BWXT","WBA","LU1852331112.SGD","IE00B894F039.SGD","BK4162","IE00BSNM7G36.USD","LU1244550577.SGD","PZZA","CI","TSLA","DRS","CCL","LU0820562030.AUD","AJG","GD","COLD","BK4588","KTOS","BK4144","VRTX","MPLN","SG9999014005.SGD","BK4592","BK4224","NOC","PEP","LU0417517546.SGD","LU0321505439.SGD","AVAV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":0.1155},{"period":"1month","weight":0.0962},{"period":"3month","weight":0.3261},{"period":"6month","weight":1.3184},{"period":"1year","weight":8.1705},{"period":"ytd","weight":8.8841}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corbus Pharmaceuticals Holdings, Inc.于2009年4月24日根据特拉华州法律注册成立。Corbus是一家精准肿瘤学公司,拥有多元化的产品组合,致力于通过将创新的科学方法引入已被广泛理解的生物途径,帮助人们战胜严重疾病。该公司的管线由两种针对实体瘤的实验药物组成:CRB-701,一种下一代抗体药物偶联物,靶向Nectin-4在癌细胞上的表达以释放细胞毒性有效载荷,CRB-601,一种抗整合素单克隆抗体,可阻断癌细胞上表达的TGFβ的激活。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.461256},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.038103},{"month":3,"riseRate":0.666667,"avgChangeRate":0.264326},{"month":4,"riseRate":0.444444,"avgChangeRate":0.005809},{"month":5,"riseRate":0.7,"avgChangeRate":0.087774},{"month":6,"riseRate":0.3,"avgChangeRate":-0.064872},{"month":7,"riseRate":0.2,"avgChangeRate":-0.089768},{"month":8,"riseRate":0.6,"avgChangeRate":0.101672},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.070914},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.122376},{"month":11,"riseRate":0.777778,"avgChangeRate":0.151585},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.091384}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals Holdings, Inc.","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals Holdings, Inc.(CRBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corbus Pharmaceuticals Holdings, Inc.(CRBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corbus Pharmaceuticals Holdings, Inc.,CRBP,Corbus Pharmaceuticals Holdings, Inc.股票,Corbus Pharmaceuticals Holdings, Inc.股票老虎,Corbus Pharmaceuticals Holdings, Inc.股票老虎国际,Corbus Pharmaceuticals Holdings, Inc.行情,Corbus Pharmaceuticals Holdings, Inc.股票行情,Corbus Pharmaceuticals Holdings, Inc.股价,Corbus Pharmaceuticals Holdings, Inc.股市,Corbus Pharmaceuticals Holdings, Inc.股票价格,Corbus Pharmaceuticals Holdings, Inc.股票交易,Corbus Pharmaceuticals Holdings, Inc.股票购买,Corbus Pharmaceuticals Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals Holdings, Inc.(CRBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corbus Pharmaceuticals Holdings, Inc.(CRBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}